Skip to main content

Jazz Pharmaceuticals plc

JAZZ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001232524

In the last 90 days, Jazz Pharmaceuticals plc insiders filed 0 open-market purchases and 6 sales; 648 institutions reported holding it in 13F filings for Q2 2026, worth $15.5B in total; no superinvestor holds it.

Members of Congress who traded JAZZ

Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.

Trades
4
Filings
4
Members
2
Buys / sells
2 / 2
Estimated volume
$81.0K
Sum of range midpoints
Members of Congress who traded JAZZ
MemberTradesBuys / sellsEst. volumeLast tradedLast filed
Daniel S. GoldmanDemocrat · House · NY31 / 2$73.0KJul 12, 2023Aug 13, 2023
Thomas R. SuozziDemocrat · House · NY11 / 0$8.00KOct 19, 2021Nov 5, 2021

Trades

Every reported trade in Jazz Pharmaceuticals plc, newest filings first.

Congress trades
MemberAssetTypeOwnerTradedFiledDelayAmountSource
Daniel S. GoldmanDemocrat · House · NYJAZZJazz Pharmaceuticals plc - Ordinary SharesSellSelfJul 12, 2023Aug 13, 202332 days$15K-$50KFiling
Daniel S. GoldmanDemocrat · House · NYJAZZJazz Pharmaceuticals plc - Ordinary SharesBuySelfMar 6, 2023Apr 17, 202342 days$15K-$50KFiling
Daniel S. GoldmanDemocrat · House · NYJAZZJazz Pharmaceuticals plc - Ordinary SharesSellSelfJan 31, 2023Feb 24, 202324 days$1K-$15KFiling
Thomas R. SuozziDemocrat · House · NYJAZZJazz Pharmaceuticals plc - Ordinary SharesBuySelfOct 19, 2021Nov 5, 202117 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.